MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds
received from revolving...
$1,336K
Net cash (used in)
provided by financing...
$872K
Canceled cashflow
$464K
Net change in cash
and cash...
-$3,310K
Canceled cashflow
$872K
Accounts receivable, net
-$6,434K
Derivative warrant
liabilities loss (gain)
-$1,257K
Depreciation and
amortization
$1,121K
Inventory write-down
$653K
Inventories
-$543K
Other operating
assets and...
-$165K
Stock-based compensation
expense
$148K
Other non-cash
adjustments
-$44K
Amortization of debt discount
and issuance costs
$27K
Payments made to
borrowings
$464K
Net cash used in
operating activities
-$4,182K
Canceled cashflow
$10,392K
Accrued liabilities
-$5,886K
Net (loss) income
-$5,618K
Prepaid expenses and
other current assets
$2,025K
Accounts payable
-$1,045K
Back
Back
Cash Flow
source: myfinsight.com
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)